Tenecteplase: all 93 studies that test it
Page 1 of 1. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.
- Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular EventsRecruitingNCT07748039Phase 3
- Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral AnticoagulantNot yet recruitingNCT07621796Phase 3
- rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time WindowRecruitingNCT07606807Phase 3
- Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR MismatchNot yet recruitingNCT07540416Phase 3
- Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time WindowNot yet recruitingNCT07476898Phase 3
- Unknown Time of Onset Stroke RePerfusIon Without Advanced ImagingRecruitingNCT07475949Phase 3
- Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical ThrombectomyNot yet recruitingNCT07471282Phase 3
- Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)RecruitingNCT07375966Phase 2
- Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)RecruitingNCT07375953Phase 2
- A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen WellRecruitingNCT07361302Phase 3
- Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 HoursRecruitingNCT07253181Phase 3
- Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 HoursRecruitingNCT07203625Phase 4
- Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.RecruitingNCT07201688Phase 3
- Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVTNot yet recruitingNCT07168278Phase 3
- Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC UsersRecruitingNCT07092709Phase 3
- Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST TrialNot yet recruitingNCT07073469Phase 3
- Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic StrokeRecruitingNCT07047014Phase 3
- Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time WindowRecruitingNCT06987305Phase 3
- Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYONDRecruitingNCT06954155Phase 3
- Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II TrialRecruitingNCT06949228Phase 2/3
- Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First DoseNot yet recruitingNCT06801054Phase 1
- Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)Not yet recruitingNCT06696131Phase 1
- Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion StrokeRecruitingNCT06658197Phase 3
- Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCTRecruitingNCT06498323Phase 4
- Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-ⅣRecruitingNCT06414499Phase 3
- ACT-GLOBAL Adaptive Platform Trial for StrokeRecruitingNCT06352632Phase 3
- ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632RecruitingNCT06320431Phase 3
- Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)RecruitingNCT06010628Phase 4
- Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy RecanalizationRecruitingNCT05624190Phase 4
- Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery OcclusionNot yet recruitingNCT05580822Phase 2
- Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENTRecruitingNCT05199662Phase 3
- Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic StrokeRecruitingNCT05199194Phase 3
- Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation StrokeRecruitingNCT05105633Phase 2/3
- A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.RecruitingNCT03998319Phase 3
- A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical ActivityCompletedNCT04915729Phase 3Results posted
- Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary EmbolismTerminatedNCT04558125Phase 4Results posted
- Tenecteplase in Patients With COVID-19CompletedNCT04505592Phase 2Results posted
- Tenecteplase in Stroke Patients Between 4.5 and 24 HoursCompletedNCT03785678Phase 3Results posted
- STrategic Reperfusion in Elderly Patients Early After Myocardial InfarctionCompletedNCT02777580Phase 4Results posted
- A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven OcclusionCompletedNCT02398656Phase 3Results posted
- TNK-tPA Evaluation for Minor Ischemic Stroke With Proven OcclusionCompletedNCT01654445Phase 2Results posted
- Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With MalignancyTerminatedNCT01580618Phase 2/3Results posted
- Clot Dissolving Treatment for Blood Clots in the LungsTerminatedNCT00680628Phase 3Results posted
- STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial InfarctionCompletedNCT00623623Phase 3Results posted
- A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart AttacksCompletedNCT00604695Phase 2Results posted
- A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous CathetersCompletedNCT00396318Phase 3Results posted
- A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) CathetersCompletedNCT00396253Phase 3Results posted
- A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis CathetersCompletedNCT00396032Phase 3Results posted
- A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous CathetersCompletedNCT00395876Phase 3Results posted
- Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)TerminatedNCT00252239Phase 2Results posted
- Minimally Invasive Surgery and RhTNK-tPA for Intracerebral Hemorrhage EvacuationCompletedNCT06668441Phase 1
- Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery OcclusionCompletedNCT06221371Phase 3
- Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5CompletedNCT06196320Phase 3
- Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time WindowCompletedNCT05752916Phase 4
- Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）Status unknownNCT05745259Phase 3
- Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery OcclusionCompletedNCT05701956Phase 3
- Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior CirculationCompletedNCT05684172Phase 2/3
- Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK)CompletedNCT05657470Phase 2/3
- Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT)TerminatedNCT05657457Phase 3
- Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)CompletedNCT05657444Phase 3
- Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before ThrombectomyStatus unknownNCT05626972Phase 3
- Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial InfarctionCompletedNCT05601999Phase 3
- Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial OcclusionsCompletedNCT05499832Phase 3
- Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）Status unknownNCT05281549Phase 2
- Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-IIICompletedNCT05141305Phase 3
- Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-ⅡCompletedNCT04797013Phase 3
- MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNKCompletedNCT04752631Phase 4
- Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in StrokeCompletedNCT04733742Phase 2/3
- Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)CompletedNCT04676659Phase 2
- CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase IICompletedNCT04516993Phase 2
- Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel OcclusionTerminatedNCT04454788Phase 3
- CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -TenecteplaseCompletedNCT04086147Phase 2
- Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the AmbulanceCompletedNCT04071613Phase 2
- Alteplase Compared to Tenecteplase in Patients With Acute Ischemic StrokeCompletedNCT03889249Phase 3
- The Norwegian Tenecteplase Stroke Trial 2TerminatedNCT03854500Phase 3
- Intramyocardial Haemorrhage in Patients With Primary STEMICompletedNCT03677466Not applicable
- Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)CompletedNCT03340493Phase 2
- Tenecteplase in Wake-up Ischaemic Stroke TrialStatus unknownNCT03181360Phase 3
- The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMICompletedNCT02835534Phase 4
- Alteplase-Tenecteplase Trial Evaluation for Stroke ThrombolysisCompletedNCT02814409Phase 3
- Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic StrokeCompletedNCT02388061Phase 2
- Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery OcclusionWithdrawnNCT02338466Phase 2
- A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)CompletedNCT02182011Phase 3
- Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)WithdrawnNCT02180204Phase 2/3
- Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic StrokeCompletedNCT02101606Phase 2
- Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic StrokeCompletedNCT01949948Phase 3
- Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)CompletedNCT01472926Phase 2
- PEITHO Pulmonary Embolism Thrombolysis StudyCompletedNCT00639743Phase 3
- Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot StudyWithdrawnNCT00431379Phase 1
- Tenecteplase Pulmonary Embolism Italian StudyTerminatedNCT00222651Phase 2
- A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)TerminatedNCT00168792Phase 4
- Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA TrialTerminatedNCT00157261Phase 3
- Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial InfarctionCompletedNCT00148460Phase 3